Corona vaccine companies are facing problems, there may be a shortage of volunteers for the trial


Posted on 6th Jan 2021 03:34 pm by rohit kumar

After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.

 

Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.

 

'Big challenge for India biotech'

He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.

 

There is also an ongoing trial of these vaccines

Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.

1 Like 0 Dislike
Previous news Next news
Other news

Kajol: 'Audience will hate my character in the series, said Kajol on playing the role of a lawyer in 'The Trial'

After impressing the world with her power-packed performances in films, Kajol is all set to foray

iPhone 15 Series: The phone will be controlled by touching this part of the iPhone 15 Series model, a hidden button will be present here.

Apple is going to introduce the iPhone 15 Series to its users today. With this series, four new i

Weather Update: IMD issues heatwave alert in nine states of the country, mercury crosses 43 degrees Celsius in UP

Heatwave conditions prevailed in many states of the country and temperatures have started rising

Paresh Rawal did not get the script of Hera Pheri 3, Akshay Kumar does not have the rights?

Hera Pheri 3 is one of the most anticipated films to date which has been in the news since its an

Engineering: Engineering students will study in 12 Indian languages, and a team of 291 people prepared books

In the upcoming academic session 2022-23, BTech second-year students of engineering colleges in 1

1200 extra buses will run for Mahakumbh on Mahashivratri, the government decided in view of the crowd

Given the availability of a large number of passengers for the last phase of Maha Kumbh Mela, 120

Coronavirus Updates: Lowest cases of corona in three months, 6915 new cases registered in 24 hours, 180 deaths

The effect of the third wave of corona infection in the country is almost over. The Ministry of H

India At UNSC Meeting: India is concerned about the safety of citizens and the condition of children in Ukraine

Amid the Russia-Ukraine war, India's Permanent Representative to the United Nations Ruchira Kambo

Unilever withdraws Dove and Tresemmé shampoos, carries cancer risk; use with caution

World's leading FMCG company Unilever has withdrawn many of its dry shampoos including Dove and T

IND vs PAK: After Haris Rauf's controversial gesture, his wife's offensive post sparks uproar on social media, watch

India defeated Pakistan by six wickets in the Asia Cup 2025 Super 4 match between Pakistan and In

Sign up to write
Sign up now if you have flare of writing..
Login   |   Register
Follow Us
Indyaspeak @ Facebook Indyaspeak @ Twitter Indyaspeak @ Pinterest RSS



Play Free Quiz and Win Cash